Marshall Wace’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-70,399
| Closed | -$1.35M | – | 3009 |
|
|
2025
Q1 | $1.35M | Sell |
70,399
-880,549
| -93% | -$16.9M | ﹤0.01% | 1552 |
|
|
2024
Q4 | $34.3M | Buy |
950,948
+137,354
| +17% | +$4.95M | 0.04% | 357 |
|
|
2024
Q3 | $34.5M | Buy |
813,594
+289,201
| +55% | +$12.3M | 0.04% | 331 |
|
|
2024
Q2 | $21.1M | Sell |
524,393
-2,595,981
| -83% | -$105M | 0.03% | 431 |
|
|
2024
Q1 | $110M | Buy |
3,120,374
+2,768,459
| +787% | +$98M | 0.17% | 102 |
|
|
2023
Q4 | $10.4M | Buy |
351,915
+172,875
| +97% | +$5.11M | 0.02% | 577 |
|
|
2023
Q3 | $3.72M | Sell |
179,040
-478,121
| -73% | -$9.93M | 0.01% | 864 |
|
|
2023
Q2 | $16.1M | Buy |
+657,161
| New | +$16.1M | 0.03% | 486 |
|
|
2023
Q1 | – | Sell |
-881,307
| Closed | -$39.6M | – | 2594 |
|
|
2022
Q4 | $39.6M | Buy |
+881,307
| New | +$39.6M | 0.09% | 220 |
|
|
2022
Q2 | – | Sell |
-24,703
| Closed | -$2.87M | – | 3166 |
|
|
2022
Q1 | $2.87M | Sell |
24,703
-55,673
| -69% | -$6.47M | 0.01% | 1489 |
|
|
2021
Q4 | $12.1M | Buy |
80,376
+64,572
| +409% | +$9.72M | 0.02% | 675 |
|
|
2021
Q3 | $1.89M | Buy |
+15,804
| New | +$1.89M | 0.01% | 1265 |
|
|
2021
Q2 | – | Sell |
-4,795
| Closed | -$424K | – | 2554 |
|
|
2021
Q1 | $424K | Buy |
4,795
+646
| +16% | +$57.1K | ﹤0.01% | 1703 |
|
|
2020
Q4 | $397K | Sell |
4,149
-9,184
| -69% | -$879K | ﹤0.01% | 1441 |
|
|
2020
Q3 | $1.51M | Buy |
13,333
+3,443
| +35% | +$391K | 0.01% | 855 |
|
|
2020
Q2 | $978K | Buy |
+9,890
| New | +$978K | 0.01% | 974 |
|
|
2020
Q1 | – | Sell |
-5,140
| Closed | -$306K | – | 2020 |
|
|
2019
Q4 | $306K | Sell |
5,140
-3,433
| -40% | -$204K | ﹤0.01% | 1225 |
|
|
2019
Q3 | $506K | Buy |
8,573
+2,839
| +50% | +$168K | ﹤0.01% | 1065 |
|
|
2019
Q2 | $370K | Buy |
+5,734
| New | +$370K | ﹤0.01% | 1107 |
|
|
2019
Q1 | – | Sell |
-14,699
| Closed | -$558K | – | 2046 |
|
|
2018
Q4 | $558K | Buy |
+14,699
| New | +$558K | 0.01% | 1059 |
|